No profile data available.
PAVmed Inc. (PAVM) is a healthcare company in the DNA testing equipment industry, based in New York, United States, with about 41 full-time employees.
It reported revenue of $71,000 for fiscal year 2025, down 97.6% from fiscal year 2024, and net income of -$3.77 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $33,000, up 450.0% from a year before. Its market capitalization was $22.31 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.
PAVmed reported $71,000 in revenue for fiscal year 2025, down 97.6% from $3.00 million in fiscal year 2024. In Q2 2026 revenue was $33,000.
$22.31 million as of October 9, 2026.
Listed companies of a similar size in the same industry (DNA testing equipment) include Cardiff Oncology, Inc. (CRDF), Sera Prognostics, Inc. (SERA), MDxHealth SA (MDXH), Aspira Women's Health Inc. (AWHL).